Ken Griffin’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 7088 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7006 |
|
|
2024
Q4 | – | Sell |
-321,885
| Closed | -$969K | – | 6844 |
|
|
2024
Q3 | $969K | Sell |
321,885
-307,760
| -49% | -$926K | ﹤0.01% | 3139 |
|
|
2024
Q2 | $2.19M | Sell |
629,645
-114,275
| -15% | -$398K | ﹤0.01% | 2355 |
|
|
2024
Q1 | $3.93M | Buy |
743,920
+425
| +0.1% | +$2.24K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $3.82M | Buy |
743,495
+734,943
| +8,594% | +$3.78M | ﹤0.01% | 1851 |
|
|
2023
Q3 | $44.8K | Sell |
8,552
-11,319
| -57% | -$59.3K | ﹤0.01% | 5111 |
|
|
2023
Q2 | $37.2K | Buy |
19,871
+19,282
| +3,274% | +$36.1K | ﹤0.01% | 5082 |
|
|
2023
Q1 | $2.2K | Sell |
589
-7,061
| -92% | -$26.4K | ﹤0.01% | 5696 |
|
|
2022
Q4 | $23.6K | Buy |
7,650
+4,227
| +123% | +$13.1K | ﹤0.01% | 5516 |
|
|
2022
Q3 | $16K | Sell |
3,423
-39,610
| -92% | -$185K | ﹤0.01% | 5575 |
|
|
2022
Q2 | $1.14M | Buy |
43,033
+8,206
| +24% | +$217K | ﹤0.01% | 3271 |
|
|
2022
Q1 | $1.3M | Buy |
34,827
+30,294
| +668% | +$1.13M | ﹤0.01% | 3477 |
|
|
2021
Q4 | $266K | Buy |
4,533
+329
| +8% | +$19.3K | ﹤0.01% | 5229 |
|
|
2021
Q3 | $346K | Buy |
4,204
+3,805
| +954% | +$313K | ﹤0.01% | 4897 |
|
|
2021
Q2 | $38K | Sell |
399
-3,208
| -89% | -$306K | ﹤0.01% | 6257 |
|
|
2021
Q1 | $230K | Buy |
+3,607
| New | +$230K | ﹤0.01% | 5296 |
|
|
2018
Q3 | – | Sell |
-506
| Closed | -$21K | – | 4753 |
|
|
2018
Q2 | $21K | Buy |
+506
| New | +$21K | ﹤0.01% | 4044 |
|
|
2017
Q4 | – | Sell |
-446
| Closed | -$21K | – | 4317 |
|
|
2017
Q3 | $21K | Buy |
+446
| New | +$21K | ﹤0.01% | 3515 |
|